Author

P. Kallio

Primary ORCID profile (0000-0003-3590-9882 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

P. KallioiD2 papers · University of Turku

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Organism:Drosophila· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

A. Aalto· 1 shared A. Meinander· 1 shared C. Haglund· 1 shared E. Gucciardo· 1 shared G. Martinez-Chacon· 1 shared J. Kreutzer· 1 shared K. Alitalo· 1 shared K. Lehti· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

A. Aalto

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

M1-linked ubiquitination facilitates NF-κB activation during sterile inflammation

A. Aalto, G. Martinez-Chacon, N. Tsyganova, J. Kreutzer, P. Kallio, M. Broemer, A. Meinander

This study shows that M1-linked ubiquitination, mediated by LUBEL, activates NF-κB during sterile inflammation in Drosophila and mammalian cells under stress conditions.

bioRxiv · Jun 3, 2021 · PreprintCell Biology

PROX1 transcription factor is a master regulator of myogenic and oncogenic features of rhabdomyosarcoma

N. Y. Gizaw, P. Kallio, T. Punger, M. Kinnunen, E. Gucciardo, K. Lehti, C. Haglund, T. Bohling, M. Varjosalo, M. Sampo, K. Alitalo, R. Kivela

This study identifies PROX1 as a master regulator of myogenic and oncogenic features in rhabdomyosarcoma, showing its role in stemness, tumor growth, and therapeutic potential through HDAC interactions.

bioRxiv · Apr 19, 2020 · PreprintCancer Biology